- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Coronavirus News Roundup: Extra Doses Found in Pfizer Vaccine, New Studies on MIS-C
Here’s the last roundup of the latest coronavirus-related news in 2020.
FDA Grants EUA to Moderna COVID-19 Vaccine
Last week, the FDA granted emergency use authorization (EUA) to Moderna’s vaccine candidate for COVID-19 for use in individuals 18 years of age and older.
Pharmacists Can Use Extra Doses Found in Pfizer COVID-19 Vaccine Vials to Expand Supply
Officials with the FDA have affirmed that pharmacists administering the Pfizer/BioNTech COVID-19 vaccine can use leftover doses in vials containing multiple doses, which may boost the US supply by up to 40%, according to reporting by Politico.
Fauci: US Still Months Away From COVID-19 Vaccine Approval for Children
Although US health care workers have started receiving the Pfizer-BioNTech COVID-19 vaccine, vaccines for children won’t be available for “months,” according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
NIH funds 8 new studies on COVID-19 related MIS-C in children
The National Institutes of Health (NIH) has awarded 8 new research grants to help identify children who are at high risk of contracting multisystem inflammatory syndrome in children (MIS-C), a severe result of COVID-19 in some children.
